[go: up one dir, main page]

DK2928455T3 - Behandling af coccidiose med intramuskulære triazinsammensætninger - Google Patents

Behandling af coccidiose med intramuskulære triazinsammensætninger Download PDF

Info

Publication number
DK2928455T3
DK2928455T3 DK13815401T DK13815401T DK2928455T3 DK 2928455 T3 DK2928455 T3 DK 2928455T3 DK 13815401 T DK13815401 T DK 13815401T DK 13815401 T DK13815401 T DK 13815401T DK 2928455 T3 DK2928455 T3 DK 2928455T3
Authority
DK
Denmark
Prior art keywords
coccidiosis
treatment
triazine compositions
intramuscular
intramuscular triazine
Prior art date
Application number
DK13815401T
Other languages
English (en)
Inventor
Hamadi Karembe
Roman Krejci
Hannelie Cilliers
Jérôme Guyonnet
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47351541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2928455(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Application granted granted Critical
Publication of DK2928455T3 publication Critical patent/DK2928455T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK13815401T 2012-12-07 2013-12-06 Behandling af coccidiose med intramuskulære triazinsammensætninger DK2928455T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306547.6A EP2740470A1 (en) 2012-12-07 2012-12-07 Treatment of Coccidiosis with intramuscular triazine composition
PCT/EP2013/075757 WO2014086959A1 (en) 2012-12-07 2013-12-06 Treatment of coccidiosis with intramuscular triazine compositions

Publications (1)

Publication Number Publication Date
DK2928455T3 true DK2928455T3 (da) 2019-11-25

Family

ID=47351541

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13815401T DK2928455T3 (da) 2012-12-07 2013-12-06 Behandling af coccidiose med intramuskulære triazinsammensætninger
DK19180399.8T DK3566695T3 (en) 2012-12-07 2013-12-06 Treatment of coccidiosis with intramuscular triazine compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19180399.8T DK3566695T3 (en) 2012-12-07 2013-12-06 Treatment of coccidiosis with intramuscular triazine compositions

Country Status (22)

Country Link
US (1) US20150320756A1 (da)
EP (4) EP2740470A1 (da)
JP (1) JP2016501253A (da)
KR (1) KR102242354B1 (da)
CN (3) CN112426426A (da)
AU (1) AU2013353983A1 (da)
BR (1) BR112015013178A2 (da)
CA (2) CA3177623A1 (da)
CL (1) CL2015001564A1 (da)
CY (1) CY1123596T1 (da)
DK (2) DK2928455T3 (da)
ES (2) ES2761574T3 (da)
HR (1) HRP20201703T1 (da)
HU (1) HUE051190T2 (da)
MX (2) MX386623B (da)
PH (1) PH12015501283B1 (da)
PL (2) PL2928455T3 (da)
PT (1) PT3566695T (da)
RU (1) RU2717821C2 (da)
SI (1) SI3566695T1 (da)
UA (1) UA115344C2 (da)
WO (1) WO2014086959A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
KR102259950B1 (ko) * 2021-02-17 2021-06-02 경상국립대학교산학협력단 복합 이온미네랄 용액을 유효성분으로 함유하는 콕시듐증의 예방 또는 개선용 조성물

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
US3970752A (en) * 1973-03-20 1976-07-20 Bayer Aktiengesellschaft Coccidiocidal compositions utilizing 1-phenyl-substituted 1,3,5-triazine
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4493826A (en) * 1982-01-25 1985-01-15 Schering Corporation Gentamicin-gleptoferron compositions
US5219853A (en) 1983-01-12 1993-06-15 Bayer Aktiengesellschaft Agent for coccidiosis
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
DE19603954C2 (de) 1996-02-05 2003-04-17 Wagon Automotive Gmbh Prallträger für ein Kraftfahrzeug
US6470017B1 (en) 1998-04-21 2002-10-22 Nippon Telegraph And Telephone Corporation Packet multiplexing apparatus
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
WO2000019964A2 (en) 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
WO2001026660A1 (en) 1999-10-08 2001-04-19 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE102004042958A1 (de) * 2004-09-02 2006-03-09 Bayer Healthcare Ag Neue antiparasitäre Kombination von Wirkstoffen
PL2532378T3 (pl) 2004-12-01 2016-11-30 Wstrzykiwacz bezigłowy
JP5180195B2 (ja) 2006-06-07 2013-04-10 アキュショット インク 無針注射器用の充薬機構
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
BRPI0910250A2 (pt) 2008-03-07 2015-09-29 Pharmajet Inc injetor intradérmico e usos do mesmo
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
US20100257667A1 (en) 2009-04-10 2010-10-14 James Kennedy Ventilated Toilet
FR2946882B1 (fr) 2009-06-18 2011-08-26 Ceva Sante Animale Suspension veterinaire gelifiee de fer
DE102009038949A1 (de) * 2009-08-26 2011-03-03 Bayer Animal Health Gmbh Neue Verwendung von heterocyclisch substituierten 1,2,4-Triazindionen
CN101947201B (zh) 2010-09-08 2011-12-28 洛阳惠中兽药有限公司 兽药纳米混悬剂及其制备方法与应用
CN102512366A (zh) 2011-12-28 2012-06-27 广州市和生堂动物药业有限公司 妥曲珠利悬浮乳剂及其制备方法
CN102743334A (zh) * 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies

Also Published As

Publication number Publication date
EP2740470A1 (en) 2014-06-11
PL2928455T3 (pl) 2020-02-28
UA115344C2 (uk) 2017-10-25
CA2892887A1 (en) 2014-06-12
MX2021006166A (es) 2021-06-30
PT3566695T (pt) 2020-10-23
US20150320756A1 (en) 2015-11-12
RU2717821C2 (ru) 2020-03-26
MX386623B (es) 2025-03-19
CN104994840A (zh) 2015-10-21
RU2015127023A (ru) 2017-01-10
CA2892887C (en) 2023-08-08
AU2013353983A1 (en) 2015-06-11
HRP20201703T1 (hr) 2020-12-25
KR20150105326A (ko) 2015-09-16
ES2761574T3 (es) 2020-05-20
MX2015007129A (es) 2015-10-20
DK3566695T3 (en) 2020-08-24
PH12015501283A1 (en) 2015-08-24
EP3566695A1 (en) 2019-11-13
EP3747429A1 (en) 2020-12-09
ES2816525T3 (es) 2021-04-05
EP3566695B1 (en) 2020-08-05
PH12015501283B1 (en) 2020-09-18
CA3177623A1 (en) 2014-06-12
KR102242354B1 (ko) 2021-04-21
PL3566695T3 (pl) 2021-04-06
CL2015001564A1 (es) 2015-10-23
JP2016501253A (ja) 2016-01-18
HUE051190T2 (hu) 2021-03-01
CN112426426A (zh) 2021-03-02
CN111714450A (zh) 2020-09-29
WO2014086959A1 (en) 2014-06-12
EP2928455A1 (en) 2015-10-14
EP2928455B1 (en) 2019-08-21
CY1123596T1 (el) 2022-03-24
BR112015013178A2 (pt) 2017-07-11
RU2020111176A (ru) 2021-09-20
SI3566695T1 (sl) 2020-12-31

Similar Documents

Publication Publication Date Title
DK2968208T3 (da) Behandling af kataplexi
DK2846809T3 (da) Behandling af myelosuppression
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK2785349T3 (da) Kombinationsbehandling af cancer
DK2844256T3 (da) Behandling af amyotrofisk lateral sklerose med tyrosinkinase-inhibitorer
DK2885010T3 (da) Fremgangsmåder til behandling med tauopati
DK2717941T3 (da) Behandling af cancer
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
IL240419A0 (en) Combining two antiviral agents to treat hepatitis c
DK2822568T3 (da) Anvendelser af caseinsammensætninger
DK3079669T3 (da) Sammensætninger med forsinket frigivelse af linaclotid
DK2897611T3 (da) Fremgangsmåder til behandling af hepatitis c
DK3106150T3 (da) Forbedrede farmaceutiske sammensætninger af pimobendan
DK2833884T3 (da) Anvendelse af ccr3-inhibitorer
DK2827862T3 (da) Formuleringer af bendamustin
DK2906580T3 (da) Behandling af amyotrofisk lateral sklerose
DK2928455T3 (da) Behandling af coccidiose med intramuskulære triazinsammensætninger
DK2852392T3 (da) Anvendelser af ikke-sulfateret chondroitin
DK2925338T3 (da) Frysetørret formulering af tat-nr2b9c
DK2800572T3 (da) Sammensætning af ellagitannin-rige ekstrakter
DK2854831T3 (da) Fremstilling af degarelix
DK4082524T3 (da) Triazinformuleringer
DK2852633T3 (da) Anvendelse af en genstand med variabel tg
DK2822301T3 (da) Bestemmelse af individuelle HRTF
DK3132684T3 (da) Behandling af fiskepopulationer med lufenuron